Mechanistically, angiotensin II and endothelin-1 directly inhibited insulin receptor substrate-1 phosphorylation, promoting systemic insulin resistance [62, 63], while hyperinsulinemia stimulated vascular smooth muscle cell proliferation and endothelin-1 secretion, further increasing vascular resistance [63, 64]. Here, EDN1 is linked to Hyperinsulinemia.